Portfolio companies for Anlong I

Company Brief Introduction Board
1NetVation JV incubator with Pfizer toward new drug R&D Yes
2Connect Leading biopharma in China in inflammatory diseases No
3To cell Manufacture technology for vaccines and antibodies Yes
4Curegen Specialty pharma in anesthesia and analgesic Yes
5GKHT Logistic platform for high end medical devices No
6Anlongmed Mobile health toward emergency medicine and CV Yes
7Three venture Leading biopharma in China focus on AB in oncology No
8Vitalong Medical hospitality platform and membership services Yes
9Lonshine Palm ultrasound and related AI in medical services Yes
10Linking Med AI in tumor radiotherapy and medical imaging Yes
11Walnut Medical record storage, publishing and applications Yes
12Biochem Leading distributor and service provider for VA hospital No
134 dimention Medical devices for cervical cancer and AI services Yes
14Vishu Big data and research toward medical publications Yes
15DL medicine NetVation JV with Hitgen toward new drug R&D Yes
16Sonmal Asthma devices and AI services collaborated with GSK Yes
17Hanyu Mitral valve clip lead player in China No
18Geneworks Molecular diagnostic device in infectious diseases Yes
19Bioceltech CAR-T R&D with non-autologous origin Yes
20Union Strong Leading AI company in Neurosurgery navigation Yes
21Laekna Leading player in oncology drug R&D in China Yes
22Wisdom Leading player in rehabilitation and AI medical devices Yes

Portfolio companies for Anlong II

Project Name Business Introduction Lead investor
1Jun Hui BiotechLiquid biopsy system for early tumor, focusing on CTC cellsYes
2NaShi biosurgerydegradable biological hemostatic glue as Medical devices Yes
3Nanjing RinanoThe leading nanopore technology, third-generation sequencingYes
4AnLong GeneTumor clinical molecular diagnostic services, technology and product developmentNo
5Sino NeurIntelligent medical devices of neurorehabilitationNo
6ZhenZhun BiotechDigital PCR instrument development, production and marketing enterprisesYes
7ArtivilaNew drug R&D through AI data mining technologyYes
8EhanriHigh-tech enterprise mainly producing 3rd-class implant instruments, medical suture materials and adhesivesNo
9SkynorHigh-tech enterprise develop the High-end micro-vascular invasive intervention productsYES
10CorreGeneTCR-T R&D; Optimized Virus productionYes
11Amador BioscienceCRO services, including immune/cellular (factor)/protein biomarkers/DNA analysis. And traditional trial management.Yes